These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3839579)

  • 1. Bone modulating factors in nephrotic children with normal glomerular filtration rate.
    Freundlich M; Bourgoignie JJ; Zilleruelo G; Jacob AI; Canterbury JM; Strauss J
    Pediatrics; 1985 Aug; 76(2):280-5. PubMed ID: 3839579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis.
    Chesney RW; Hamstra A; Rose P; DeLuca HF
    Int J Pediatr Nephrol; 1984 Mar; 5(1):1-4. PubMed ID: 6715110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
    Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
    J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.
    Malluche HH; Goldstein DA; Massry SG
    J Clin Invest; 1979 Mar; 63(3):494-500. PubMed ID: 429568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone histology in steroid-treated children with non-azotemic nephrotic syndrome.
    Freundlich M; Jofe M; Goodman WG; Salusky IB
    Pediatr Nephrol; 2004 Apr; 19(4):400-7. PubMed ID: 14991389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
    Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
    Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium and vitamin D metabolism in children with nephrotic syndrome.
    Freundlich M; Bourgoignie JJ; Zilleruelo G; Abitbol C; Canterbury JM; Strauss J
    J Pediatr; 1986 Mar; 108(3):383-7. PubMed ID: 3485195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency.
    Rude RK; Adams JS; Ryzen E; Endres DB; Niimi H; Horst RL; Haddad JG; Singer FR
    J Clin Endocrinol Metab; 1985 Nov; 61(5):933-40. PubMed ID: 3840173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
    Portale AA; Booth BE; Halloran BP; Morris RC
    J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and calcium metabolism in children with nephrotic syndrome of normal renal function.
    Huang JP; Bai KM; Wang BL
    Chin Med J (Engl); 1992 Oct; 105(10):828-32. PubMed ID: 1291200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible mechanism of impaired calcium and vitamin D metabolism in nephrotic rats.
    Mizokuchi M; Kubota M; Tomino Y; Koide H
    Kidney Int; 1992 Aug; 42(2):335-40. PubMed ID: 1328752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationship of serum 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D in juvenile renal osteodystrophy after therapy with 25-hydroxyvitamin D3.
    Taylor A; Norman ME
    Metab Bone Dis Relat Res; 1982; 4(4):255-61. PubMed ID: 6897822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone histology in patients with nephrotic syndrome and normal renal function.
    Mittal SK; Dash SC; Tiwari SC; Agarwal SK; Saxena S; Fishbane S
    Kidney Int; 1999 May; 55(5):1912-9. PubMed ID: 10231454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential changes in vitamin D and calcium metabolism after successful renal transplantation.
    Saha HH; Salmela KT; Ahonen PJ; Pietilä KO; Mörsky PJ; Mustonen JT; Lalla ML; Pasternack AI
    Scand J Urol Nephrol; 1994 Mar; 28(1):21-7. PubMed ID: 8009188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of metabolic bone disease in adult patients with the nephrotic syndrome and normal renal function.
    Korkor A; Schwartz J; Bergfeld M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E
    J Clin Endocrinol Metab; 1983 Mar; 56(3):496-500. PubMed ID: 6822651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypomagnesaemia-induced hypocalcaemia: concentrations of parathyroid hormone, prolactin and 1,25-dihydroxyvitamin D during magnesium replenishment.
    Leicht E; Schmidt-Gayk H; Langer HJ; Sneige N; Biro G
    Magnes Res; 1992 Mar; 5(1):33-6. PubMed ID: 1591141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of the intestinal 1,25-dihydroxyvitamin D3 receptor to magnesium depletion in the rat.
    Lemay J; Gascon-Barré M
    Endocrinology; 1992 May; 130(5):2767-77. PubMed ID: 1315257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D metabolites in childhood nephrotic syndrome.
    Grymonprez A; Proesmans W; Van Dyck M; Jans I; Goos G; Bouillon R
    Pediatr Nephrol; 1995 Jun; 9(3):278-81. PubMed ID: 7632510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of successful renal transplant to produce appropriate levels of 1,25-dihydroxyvitamin D.
    Fleseriu M; Licata AA
    Osteoporos Int; 2007 Mar; 18(3):363-8. PubMed ID: 17061149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.